Dear Editor,

Dr.Takemoto et al. recently published the report of Intra-abdominal *actinomycosis* resulting in a difficult-to-diagnose intraperitoneal mass: A case study report \[[@bib0005]\].

The genus *actinomyces* is one of the *actinomycete* families (actinomycetaceae) that was described in 1887 by Bollinger from the lumpy jaw of cattle \[[@bib0010]\]. These microorganisms are gram-positive, filamentous, fastidious and anaerobic bacteria, which are not acid-fast and non-motile, causing granulomatous infection in the cervicofacial, thoracic, abdominal and pelvic region of the human body \[[@bib0015],[@bib0020]\].

Detection of *actinomyces* spp. is necessary and important for the final diagnosis, appropriate treatment, and epidemiological studies. Identification of *actinomyces* using phenotypic tests (such as gram-staining and microscopic evaluation, colony morphology, gelatin, urea, starch and aesculin hydrolysis, acetoin production, nitrate reduction, pyrazinamidase activity, hydrolysis of hippurate and API system) are laborious, time-consuming, expensive, difficult for standardization, and needs expert technicians; whereas molecular methods such as sequencing of 16S rRNA, *atpA* (ATP synthase F1, alpha subunit), *rpoB* (RNA polymerase beta subunit), *pgi* (glucose-6-phosphate isomerase), *metG* (methionyl-tRNA synthase), *gltA* (citrate synthase I) and *gyrA* (DNA gyrase subunit A) are rapid, reliable and accurate ways in identification of *actinomyces* species, especially in urgent cases \[[@bib0015]\].

Prescribing high dose of penicillin G and surgery are traditional treatments for actinomycosis. However, antibiotic therapy cannot be standardized for actinomycosis, since it depends on the *actinomyces* species that are the causative agents of the infection, as well as clinical and radiological responses; although based on the literatures, short term treatment consists of penicillin and amoxicillin; penicillin G followed by oral penicillin VK or clindamycin are efficient for the treatment of actinomycosis \[[@bib0020],[@bib0025]\].

*Dear Sir*,

I hereby request the authors to kindly respond to the following points to clear my ambiguities.1Please describe the actinomycosis isolation method, which was not stated in the report.2According to reports, other genes such as a*ctinomadura madurae*, a*ctinomyces odontolyticus*, a*ctinomyces meyeri*, and *actinomyces naeslundii* (similar to *actinomyces israelii*) have the same phenotypic features and can cause of sulfur granule \[[@bib0030]\]; Please explain how a*ctinomyces israelii* was detected in the species level.
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